1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Portable Nanopore sequencing solution for next-generation HIV drug resistance testing.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tackling HIV drug resistance is one of major challenges for ending AIDS epidemic, but the elevated expense of cutting-edge genomics hampers the advancement of HIV genotype testing for clinical care.

          Related collections

          Author and article information

          Journal
          J Clin Virol
          Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
          Elsevier BV
          1873-5967
          1386-6532
          Apr 2024
          : 171
          Affiliations
          [1 ] Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
          [2 ] Los Angeles General Medical Center, Los Angeles, CA, United States; Department of Medicine and Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
          [3 ] Department of Medicine and Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
          [4 ] Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. Electronic address: hayoun@usc.edu.
          Article
          NIHMS1959120 S1386-6532(24)00001-5
          10.1016/j.jcv.2024.105639
          10947882
          38219684
          d3967e63-d146-48ea-9683-446794c78f31
          History

          HIV drug resistance,Portable Nanopore sequencing,Cross-linked drug resistance mutations

          Comments

          Comment on this article